Enter the inaugural Cell Therapy for Autoimmune Disease Summit, a pioneering platform singularly focused on uniting and empowering this community for the first time. Experts will delve into cutting-edge frontiers of pre-clinical, translational, and clinical advancements encompassing all cell-based therapies, including CAR-T, Treg, and MSC, with the shared objective of developing better therapies for patients with chronic autoimmune diseases.

Don’t miss out on your opportunity to network with 80+ key opinion leaders including Cabaletta Bio, Kyverna Therapeutics, AstraZeneca, Quell Therapeutics, Novartis, and more. Learn more – https://ter.li/6xwjrk